China Grapples To Get A Handle On Reporting Mechanisms For Adverse Drug Reactions
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - When China's State FDA released figures for cases of adverse drug reactions in late January, it touched on an underreported issue and one that may prove difficult to tackle